Different from consistent increases in n-10 GP isomers, breast cancer cells of different subtypes show entirely different sensitivity to SCD1 inhibition with diverse tendencies of the ratios of n-9/n-7 isomers in C18:1-containing GPs. This evidence concerns the gene SCD and breast carcinoma.